Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: A role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation

Immunology and Cell Biology

Volumn 83, Issue 5, 2005, Pages 525-535

  Lebre, M Cristina ^a   Burwell, Tim ^b   Vieira, Pedro L ^a,c   Lora, Jose ^b   Coyle, Anthony J ^b   Kapsenberg, Martien L ^a   Clausen, Björn E ^a   De Jong, Esther C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokine; Dendritic cell; Helper T cell (Th cell, inflammation, Th0, Th1, Th2)

Indexed keywords

CARBON TETRACHLORIDE; CD40 LIGAND; CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ARTICLE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; GENE SEQUENCE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; HUMANS; INFLAMMATION; JURKAT CELLS; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 29144451837     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01365.x     Document Type: Article

References (43)

1. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 360-6.
2. Levy DE, Marié I, Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 2003; 15: 52-8.
3. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. N. Engl. J. Med. 1996; 2: 1174-8.
4. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001; 2: 123-8.
5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-7.
6. Gerard C, Rollins BJ. Chemokines and disease. Nat. Immunol. 2001; 2: 108-15.
7. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-102.
8. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev. 2000; 177: 134-40.
9. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Ann. Rev. Immunol. 2000; 18: 593-620.
10. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
11. Foxman EF, Campbell JJ, Butcher EC. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 1997; 139: 1349-60.
12. Vulcano M, Albanesi C, Stoppacciaro A et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 2001; 31: 812-22.
13. Sallusto F, Palermo B, Lenig D et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999; 29: 1617-25.
14. Vissers JLM, Hartgers FC, Lindhout E, Teunissen MBM, Figdor CG, Adema GJ. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukoc. Biol. 2001; 69: 785-93.
15. Adema GJ, Hartgers F, Verstraten R et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713-17.
16. Tang HL, Cyster JG. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284: 819-22.
17. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998; 187: 655-60.
18. Breitfeld D, Ohl L, Kremmer E et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 2000; 192: 1545-52.
19. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001; 194: 769-79.
20. Vissers JL, Hartgers FC, Lindhout E, Figdor CG, Adema GJ. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur. J. Immunol. 2001; 31: 1544-9.
21. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998; 187: 129-34.
22. D'Ambrosio D, Iellem A, Bonecchi R et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 1998; 161: 5111-15.
23. Hedrick JA, Zlotnik A. Lymphotactin. Clin. Immunol. Immunopathol. 1998; 87: 218-22.
24. Kalinski P, Hilkens CMU, Snijders A, Snijdewint FGM, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 1997; 159: 28-35.
25. Hilkens CMU, Kalinski P, de Boer M, Kapsenberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells towards the Th1 phenotype. Blood 1997; 90: 1920-6.
26. Kalinski P, Schuitemaker JHN, Hilkens CMU, Wierenga LA, Kapsenberg ML. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 1999; 162: 3231-6.
27. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998; 161: 2804-9.
28. Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques 2001; 31: 186-94.
29. Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML, Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 2000; 164: 4507-12.
30. de Jong EC, Vieira PL, Kalinski P et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 2002; 168: 1704-9.
31. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 1999; 189: 611-14.
32. Kalinski P, Hilkens CMU, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 1999; 20: 561-7.
33. Liu Y-J, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross regulation. Nat. Immunol. 2001; 2: 585-9.
34. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994; 12: 881-922.
35. Loetscher P, Uguccioni M, Bordoli L et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344-5.
36. Radstake TR, van d V, ten Brummelhuis M et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann. Rheum. Dis. 2005; 64: 359-67.
37. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 1998; 19: 568-74.
38. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 1999; 11: 81-8.
39. Yoneyama H, Narumi S, Zhang Y et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 2002; 195: 1257-66.
40. Won YH, Sauder DN, McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br. J. Dermatol. 1994; 130: 312-19.
41. Cumberbatch M, Dearman RJ, Kimber I. Stimulation of Langerhans cell migration in mice by tumour necrosis factor alpha and interleukin 1 beta. Adv. Exp. Med. Biol. 1997; 417: 121-4.
42. Moll H, Fuchs H, Blank C, Rollinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 1993; 23: 1595-601.
43. Katou F, Ohtani H, Nakayama T et al. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. Am. J. Pathol. 2001; 158: 1263-70.